Home › Compare › ELPQF vs ABBV
ELPQF yields 3.75% · ABBV yields 3.06%● Live data
📍 ELPQF pulled ahead of the other in Year 2
Combined, ELPQF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ELPQF + ABBV for your $10,000?
El Puerto de Liverpool, S. A. B. de C. V., together with its subsidiaries, operates a chain of department stores in Mexico. The company operates through Liverpool Commercial, Suburbia Commercial, and Real Estate segments. Its stores offer various products, such as clothes and accessories for men, women, and children; household goods; furniture; cosmetics; and other consumer products. As of December 31, 2020, it operated 122 department stores under the Liverpool name; 124 specialized boutiques; and 165 stores under the Suburbia name. The company is also involved in the operation of liverpool.com.mx and suburbia.com.mx websites. In addition, it owns and leases 28 shopping malls under the Galerías name; and provides credit cards under the Liverpool and Liverpool Premium Card name, as well as Suburbia and Suburbia VISA credit cards. Further, the company operates boutiques under the Banana Republic, GAP, Pottery Barn, West Elm, and Williams-Sonoma names. El Puerto de Liverpool, S. A. B. de C. V. as founded in 1847 and is headquartered in Mexico City, Mexico.
Full ELPQF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.